In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SurroMed Inc.

www.surromed.com

Latest From SurroMed Inc.

The New Service Model for Diagnostics

Amidst a slew of disappointing IPOs, the moderate success of Genomic Health's IPO signals investor interest in a new diagnostics model: a combination product/service business -- technologically agnostic -- focused on coming up with an answer to a specific yes/no question that will either lead to or discourage an expensive therapy by a specialty physician audience. Several other start-ups are following the same model.
BioPharmaceutical Medical Device

The Challenge of Making Money from Biomarkers

VCs won't go near traditional diagnostics. But some are starting to bet on biomarkers that expedite drug R&D and commercialization. Only one problem: they've yet to come up with the right business model
BioPharmaceutical Medical Device

Clinical Research Tools: A Special Situation for Venture Investors and Entrepreneurs

Five years after the genomics bubble burst and financing doors shut, a small window may be opening for research tool suppliers that help pharma improve R&D efficiency and cost structure. But clinically-oriented research companies face particular challenges, notably how to build a business where customer adoption is slow but technology is evolving rapidly and investors are impatient.
BioPharmaceutical Strategy

Microarrays Aim for Center Stage

Accepted in discovery, microarrays are paving the way for biomarker development and eventually, molecular diagnostics.
BioPharmaceutical Platform Technologies
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Bioinformatics
      • Genomics-Proteomics
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
    • Molecular Diagnostics & Genetic Testing
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • SurroMed Inc.
  • Senior Management
  • Gordon Ringold, PhD, Chmn. & CEO
    Howard Schulman, PhD, VP, R&D
    Michael Natan, PhD, CTO
  • Contact Info
  • SurroMed Inc.
    Phone: (650) 855-9079
    1060 East Meadow Cir.
    Palo Alto, CA 94303
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register